Sonova H Ag (SOON)
SIX Swiss Exchange · Switzerland · prices in CHF · close of 22 Oct 2026
Key indicators
| Last close | CHF 281.00 |
|---|---|
| 52-week range | 163.00 – 281.40 |
| Return, 1 month / 3 months | +17.3% / +32.9% |
| Return, 1 year / 3 years | +25.0% / +41.3% |
| Trend | Uptrend |
| RSI (14) | 80 |
| Volatility (1 year) | 27.8% |
| Worst drawdown (1 year) | -27.1% |
| Average daily value traded | 33.39M CHF |
| Dividend yield | 1.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Sonova is a Swiss hearing care company based in Staefa. It develops and makes hearing aids, which it markets under brands such as Phonak and Unitron, and it also produces cochlear implants through its Advanced Bionics business. Its customers are hearing care professionals, clinics and dispensers who fit these devices for people with hearing loss, and it supplies accessories and fitting software alongside the instruments. The company serves markets in many countries through its own distribution and retail operations.
On this site Sonova H Ag appears as a stock on the SIX Swiss Exchange (Switzerland), code SOON, with prices in Swiss francs (CHF). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Sonova H Ag (SOON) trades on the SIX Swiss Exchange in Switzerland. It last closed at CHF 281.00 on 22 October 2026.
Its price-based Market X-Ray is 73 out of 100 (a strong price profile), ranking 21 of 225 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 25.0% and over the last three months it rose 32.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on SIX Swiss Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 94 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 34.7% | ||
| From 52-week high | 0.0% | ||
| Momentum | 80 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 32.9% | ||
| 6-month return | 60.0% | ||
| 12-month return, skipping the last month | 6.5% | ||
| Stability (higher is calmer) | 48 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 27.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -27.1% | ||
| Liquidity | 89 · Strong | Trades actively. | |
| Average daily value traded | 33.39M CHF | ||
| Zero-volume days | 0.0% | ||
| Income | 41 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.7% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +2.5% |
|---|---|
| 1 month | +17.3% |
| 3 months | +32.9% |
| 6 months | +60.0% |
| 1 year | +25.0% |
| 3 years | +41.3% |
| 5 years | −17.7% |
Signals
| 50-day / 200-day average | 246.57 / 208.58 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 4.87 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 19 Jun 2026 | CHF 4.7000 |
| 13 Jun 2025 | CHF 4.4000 |
| 13 Jun 2024 | CHF 4.3000 |
| 14 Jun 2023 | CHF 4.6000 |
| 17 Jun 2022 | CHF 4.4000 |
| 17 Jun 2021 | CHF 3.2000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on SIX Swiss Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.